









A multicentre, cross-sectional study investigating the prevalence of hypertensive disease in 
patients presenting for elective surgery in the Western Cape, South Africa 
Karen van der Spuy1, Marcelle Crowther2, Marcin Nejthardt3, Francois Roodt4, Jody Davids5, John 
Roos6, Estie Cloete7, Tania Pretorius8, Gareth Davies9, Jessica van der Walt10, Christo van der 
Westhuizen11, Margot Flint12, Justiaan Swanevelder13, and Bruce Biccard12. 
 
1. K. van der Spuy, BSc Honours (Physiotherapy) (UWC), MBChB (UCT). Registrar, Department 
of Anaesthesia and Perioperative Medicine, Groote Schuur Hospital, University of Cape Town, 
Anzio Road, Observatory, 7925, Cape Town, South Africa. 
2. Marcelle Crowther, MBChB (US). Registrar, Department of Anaesthesia and Perioperative 
Medicine, Groote Schuur Hospital, University of Cape Town, Anzio Road, Observatory, 7925, 
Cape Town, South Africa. 
3. Marcin Nejthardt, BSc Honours (Physiology) (Wits), MBBCh (Wits), DA (SA), FCA (SA). 
Specialist Anaesthetist, Department of Anaesthesia and Perioperative Medicine, Groote Schuur 
Hospital and Red Cross War Memorial Children’s Hospital, University of Cape Town, Anzio 
Road, Observatory, 7925, Cape Town, South Africa. 
4. Francois Roodt, MBChB (Pta), FCA (SA). Specialist Anaesthetist, Department of Anaesthesia 
and Perioperative Medicine, Groote Schuur Hospital and Red Cross War Memorial Children’s 
Hospital, University of Cape Town, Anzio Road, Observatory, 7925, Cape Town, South Africa. 
5. Jody Davids, MBChB (US), DA (SA), MMed (UFS), FCA (SA). Specialist Anaesthetist, 
George Regional Hospital, Davidson Road, George, 6530, Western Cape, South Africa. 
6. John Roos, MBChB (UCT), DA (SA), FCA (SA). Specialist Anaesthetist and Head of 
Department of Anaesthesiology, Mitchell’s Plain Hospital, AZ Berman Drive, Lentegeur, 7786, 
Cape Town, Western Cape, South Africa. 
7. Estie Cloete, MBChB (Pret), DA (SA), FCA (SA). Specialist Anaesthetist, Department of 
Anaesthesia and Perioperative Medicine, Groote Schuur Hospital and New Somerset Hospital, 
University of Cape Town, Anzio Road, Observatory, 7925, Cape Town, South Africa. 
8. Tania Pretorius, MBChB (US), DA (SA), FCA (SA), MMed (UCT). Specialist Anaesthetist, 
Paarl Provincial Hospital, Bergriver Boulevard, Paarl, 7646, Western Cape, South Africa. 
9. Gareth Davies, MBChB (US), FCA (SA). Specialist Anaesthetist, Paarl Provincial Hospital, 
Bergriver Boulevard, Paarl, 7646, Western Cape, South Africa. 
10. Jessica van der Walt, MBChB (Wits), DCh (SA), DA (SA), FCA (SA), MMed (UCT). 
Specialist Anaesthetist and Head of Department of Anaesthesiology, Victoria Hospital, Alphen 
Hill Road, Wynberg, 7800, Cape Town, Western Cape, South Africa. 
11. Christo van der Westhuizen, MBChB (US), DA (SA), FCA (SA), MMed (UCT). Specialist 
Anaesthetist, Worcester Hospital, Murray Street, Worcester, 6849, Western Cape, South Africa.  
12. Margot Flint, BSc Medical Physiology (US), HSc (US), MSc (US), PhD (US). Chief Scientific 
Officer, Department of Anaesthesia and Perioperative Medicine, Groote Schuur Hospital, 
University of Cape Town, Anzio Road, Observatory, 7925, Cape Town, South Africa. 
13. Justiaan Swanevelder, MBChB (US), DA (SA), FCA (SA), MMed (US), FRCA (UK). 
Professor, Head of Department, Department of Anaesthesia and Perioperative Medicine, Groote 
Schuur Hospital, University of Cape Town, Anzio Road, Observatory, 7925, Cape Town, South 
Africa. 
14. Bruce Biccard, MBChB (UCT), MMedSci (UKZN), FCA (SA), PhD (UKZN). Honorary 
Associate Professor, Second Chair, Department of Anaesthesia and Perioperative Medicine, 
Groote Schuur Hospital, University of Cape Town, Anzio Road, Observatory, 7925, Cape 





















The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
 
Published by the University of Cape Town (UCT) in terms 
of the non-exclusive license granted to UCT by the author. 
 
	 2	
Corresponding Author Contact Details:  
Karen van der Spuy 
Email: karenvdspuy@gmail.com  
Cell: +27 82 9285393  
 
Department of Anaesthesia & Perioperative Medicine  
Groote Schuur Hospital  
Telephone: +27 21 404 5001/3  
Postal Address:  
Department of Anaesthesia and Perioperative Medicine  
D 23 
Groote Schuur Hospital  





• Preoperative Blood Pressure 
• Hypertension 
• Hypertensive Risk Factors  
• Target Organ Damage 
• Treatment Compliance 
• Perioperative Medicine 










Hypertension is common, affecting over one billion people worldwide. Importantly, in Sub-Saharan 
Africa hypertensive disease not only affects the older population group, but is becoming 
increasingly prevalent in younger patients. In South Africa, over 30% of the adult population has 
hypertension, making it the single most common cardiovascular risk factor and the predominant 
contributor to cardiovascular disease and mortality.  
In non-cardiac surgical patients, elevated blood pressure is the most common perioperative 
comorbidity encountered with an overall prevalence of 20-25%, and it remains poorly controlled in 
low and middle-income countries. Furthermore, hypertension in the perioperative setting may 
adversely affect patient outcome. It thus not only flags possible perioperative challenges to 
anaesthesiologists, but also identifies patients at risk of long-term morbidity and mortality. 
 
Objectives: 
The primary objective of this study was to determine the prevalence and severity of hypertension in 
elective adult surgical patients in the Western Cape. 
 
Results: 
The study population included all non-cardiac, non-obstetric, elective surgical patients from seven 
hospitals in the Western Cape during a one-week period.  Hypertension, defined as having had a 
previous diagnosis of hypertension or meeting the blood pressure criteria of more than 140/90 
mmHg, was identified in 51.8% of patients during the preoperative assessment. Significantly, 
newly diagnosed hypertension was present in 9.6% of all patients presenting for elective surgery. 
Although 98.1% of the known hypertensive patients were on antihypertensive therapy, 36.9% were 
inadequately controlled. Numerous reasons exist for this but notably 32% of patients admitted to 




This study suggests that the perioperative period may be an important opportunity to identify 
undiagnosed hypertensive patient.  The perioperative encounter may have a significant public 
health implication in facilitating appropriate referral and treatment of hypertension to decrease 
long-term cardiovascular complications in South Africa. 
 
 





Hypertension is common, affecting over one billion people worldwide, and is responsible for over 
seven million deaths annually.[1] The presence of hypertension increases the risk of myocardial 
infarction, heart failure, renal failure and cerebrovascular disease.[2] Importantly, in Sub-Saharan 
Africa hypertensive disease not only affects the older population group, but is becoming 
increasingly prevalent in younger patient groups.[3]  In South Africa, over 30% of the adult 
population have hypertension,[4] and it remains the single most common cardiovascular risk factor 
and predominant contributor to cardiovascular disease and mortality.[5,6] 
In non-cardiac surgical patients, elevated blood pressure is the most common perioperative 
comorbidity encountered, with an overall prevalence of 20-25%,[7] and it remains poorly controlled 
in low and middle-income countries.[8,9] Furthermore, hypertension in the perioperative setting may 
adversely affect patient outcome.[10] Hypertension therefore poses perioperative challenges to 
anaesthesiologists, while simultaneously identifying patients at risk of long-term morbidity and 
mortality.[11,12] 
The diagnosis of hypertension and initiation of treatment is most frequently made in the primary 
health care setting. However, in a resource limited environment, the perioperative period provides 
clinicians a unique opportunity to identify patients with hypertensive disease, educate patients 
about the disease, and initiate appropriate therapy. Furthermore, this period provides the 
opportunity to refer patients for further investigation or follow up at peripheral health care centres 
for on-going management, thus aiding the decentralization of chronic, long-term care. The efficient 
identification and diagnosis of hypertension in the perioperative period, could therefore be seen as 
an effective utilisation of planned surgical admission by simultaneously addressing a primary health 
care need and this may serve as an efficient health care strategy in reducing long-term 
cardiovascular morbidity and mortality.[13,14] Identification and/or optimisation of hypertensive 
management in the perioperative period is an attractive healthcare intervention in a resource limited 
environment such as South Africa, particularly when considering difficulties with  primary 
healthcare access and treatment compliance.  
The primary objective of this study was to describe the prevalence and severity of hypertension in 
non-cardiac, non-obstetric, elective adult surgical patients in the Western Cape, in order to 
determine whether perioperative screening can be used to supplement primary healthcare 
management of hypertension, through developing effective strategies for the diagnosis and 




The primary aim of the study was to describe the prevalence and stages of hypertension in adult 
patients presenting for non-cardiac, non-obstetric elective surgery in all surgical disciplines at seven 
hospitals in the Western Cape. 
The secondary aims of the study were to identify; i) hypertension associated target organ damage, 
ii) risk factors associated with hypertension, and iii) to assess compliance with prescribed 
hypertensive therapy.   
This was a multicentre, prospective, observational study conducted at seven hospitals in the 
Western Cape; one tertiary level institution, Groote Schuur Hospital, and six secondary level 
institutions which included George, Mitchells Plain, New Somerset, Paarl, Victoria and Worcester 
Hospitals. Ethics approval was obtained for all institutions (HREC Ref: 661/2016; 708/2016 and 
NHRD WC_2016RP55_876) and written informed consent was sought prior to patient enrolment in 
the study.  The trial was registered on the South African National Clinical Trial Register 
(NCT03157661).  
 
All adult, non-cardiac, non-obstetric patients, admitted the day before elective surgery during the 
study period were eligible for inclusion. Exclusion criteria were patient refusal, day case surgery (as 
no preceding day preoperative assessment was possible) and patients not requiring an anaesthetic. 
Recruitment was from 7am Monday to 7pm Friday of the week chosen for the study.   
 
Data was collected by anaesthesia medical officers, registrars and specialists assigned to each of the 
surgical lists at the various institutions. Routine preoperative information was recorded on a 
specifically designed paper case report form (CRF) and then captured onto the Research Electronic 
Data Capture (REDcap) web-based application. Compliance with medical therapy was assessed 
using the Morisky Medication Adherence Questionnaire.[15,16] A positive response to two or more 
of the four questions was considered as non-compliance with antihypertensive treatment. 
 
Assessment of preoperative hypertension was evaluated using the South African Hypertension 
practice guidelines.[4] All blood pressure measurements were performed with an appropriately sized 
non-invasive blood pressure cuff, using an automated oscillometric method of blood pressure 
measurement. If the patient was found to have a systolic blood pressure of ≥140 mmHg or a 
diastolic blood pressure of ≥90 mmHg, then two further measurements were performed at least 5 
minutes apart. The lowest of the three readings was taken as the preoperative blood pressure. 
Patients who after these three blood pressure readings still had a systolic blood pressure of ≥140 
mmHg or a diastolic blood pressure of ≥90 mmHg where considered to be hypertensive.[4] 
 
Categorical variables were described as proportions and compared using chi-square tests and 
Fisher’s exact tests, as appropriate. Continuous variables were described as mean and standard 
deviation (SD) or median and interquartile range (IQR), and compared using t-tests or one-way 
ANOVA as appropriate. Data was analysed using Statistical Package for the Social Sciences 






The Hypertension and Surgery Study (HaSS) included seven state hospitals in the Western Cape 
(Supplementary Table). The patient recruitment, prevalence and control of hypertension is shown in 
Figure 1. Of the 397 patients who were screened, five refused to participate, and four did not meet 
inclusion criterion. Six patients were excluded from the analysis due to incomplete datasets. 
Analysis was possible on full datasets of 382/388 (98.5%) consenting patients. 
 
Please insert Suppl. Table somewhere here please 
 
Please insert Figure 1 somewhere here please 
 
Previously diagnosed hypertension was present in 160 (41.9%) patients, whilst newly diagnosed 
hypertension was found in a further 38 (9.9%) patients.  Prevalence of hypertension, defined as 
having had a previous diagnosis of hypertension or meeting the blood pressure criteria of more than 
140/90 mmHg, was thus 198/382 (51.8%, 95% CI 46.8-56.8) in the preoperative assessment.   
 
The characteristics of the recruited patients are shown in Table 1. Hypertensive patients were older, 
carried more risk factors for hypertension and had more co-morbidities as reflected by the higher 
American Society of Anesthesiologists (ASA) grading. Hypertensive patients had significantly 
more target organ damage, specifically coronary artery disease (CAD), heart failure (HF), advanced 
retinopathy, cerebrovascular disease (CVA), chronic renal disease, peripheral arterial disease 
(PAD), diabetes and dyslipidaemia. 
 
Please insert Table 1 somewhere here please 
 
The severity of hypertension is shown in Table 2. Of all the hypertensive patients, 99/198 (50.0%, 
95% CI 43.0 – 57.0%) were found to have a blood pressure greater than 140/90 mmHg. Despite the 
vast majority of known hypertensive patients (157/160; 98.1%) being on anti-hypertensive therapy 
preoperatively, inadequate blood pressure control was present in 61/160 (38.1%, 95% CI 31.2 – 
46.3%).  
 
Please insert Table 2 somewhere here please 
 
Table 3 lists the most common antihypertensive therapies in the study population. In the patients 
who presented for surgery with a diagnosis of hypertension, treatment non-compliance was 
reported in 39/157 (25%, 95% CI 18.2 – 31.8%) (Table 4). A third of patients (50/156) taking anti-
hypertensive medication admitted to forgetting to take their medication. Patient factors were the 
most common cause of treatment non-compliance. 
 







Statement of principal findings:  
Five out of every ten patients presenting for elective surgery in the Western Cape are hypertensive. 
Of these, 20% are undiagnosed and 40% are inadequately controlled. This study suggests that the 
perioperative period may be an important opportunity to identify undiagnosed hypertension as well 
as improve the management of known hypertensive patients in South Africa.  
 
Secondly, once a patient is diagnosed with hypertension, access to medication in the community is 
good, but compliance of the patient to therapy becomes the more important determinant of 
subsequent hypertensive control.  
 
These data suggest that the perioperative period could supplement primary healthcare services, 
through perioperative screening, treatment initiation and referral. This needs to be coupled with an 
appropriate educational programme to ensure subsequent patient compliance with therapy on 
discharge. This dual-pronged approach to hypertension in surgical patients therefore has the 
potential for a large public health benefit in South Africa.   
 
Strengths: 
This is a multicentre, prospective observational study of hypertension in the Western Cape. The 
ability to follow the South African Hypertension Guidelines in confirming the diagnosis of 
hypertension on the day prior to surgery in this study increases our confidence that our results do 
reflect the true burden of hypertensive disease in preoperative surgical patients. We expect this data 
to be broadly generalizable across the Western Cape, and possibly across South Africa for patients 
from similar social circumstances.  
 
Limitations: 
It is possible that the prevalence of hypertension may be overestimated in this cohort. Although the 
evaluation of hypertension was made in elective surgical patients on the day preceding surgery, it is 
possible that some of the patients may have been anxious, and hence spuriously fulfilled the 
diagnostic criteria. Furthermore, this study excluded all emergency cases, thus a true prevalence of 
hypertension in patients presenting for all surgery is not possible. We would however expect the 
prevalence of hypertension to be higher in patients presenting for emergency surgery as they are 
likely to have more co-morbid disease compared to the elective population. 
 
Finally, the information related to compliance with medical therapy should be viewed with some 
caution as it is based on a relatively small sample size. 
 
Implications of this study: 
It is estimated that 60% of the world’s population is hypertensive, as defined by The World 
Hypertension Society/International Society of Hypertension.[17]  
In the African region the prevalence of hypertension is estimated at 46% for adults aged 25 and 
above. The number of adults with hypertension in 2025 is predicted to increase by about 60%, with 






In Sub-Saharan Africa, despite the high burden imposed by communicable diseases, hypertension 
has emerged as a significant medical and public health problem and is regarded as one of the 
continent’s greatest health challenges after HIV/AIDS.[1]   It is estimated that if the 10 – 20 million 
people who are believed to have hypertension in Sub-Saharan Africa were treated effectively, about 
250 000 deaths could be prevented annually.[19] 
 
According to the South African Hypertension Practice Guidelines, 30.4% of our adult population 
has hypertension.[2] This chronic disease is regarded as the single most prevalent cardiovascular risk 
factor and predominant contributor to cardiovascular disease related morbidity and mortality.[1]  In 
the 2015 South African mortality statistics,  cerebrovascular disease ranked 3rd, accounting for 
5.0% of national deaths, heart disease ranked 5th, accounting for 4.8%, and hypertension related 
diseases ranked 7th, accounting for 4.2% of all national natural causes of death.[20] 
 
Although hypertension is not directly linked to poor perioperative outcomes, it is associated with 
long-term cardiovascular morbidity and mortality.[2] Treating hypertension improves long term 
outcome.[13] This study suggests that perioperative evaluation of blood pressure has the potential to 
i) identify undiagnosed hypertension in 10% of all adult patients presenting for elective surgery, ii) 
provide surveillance for the adequacy of management of hypertension in the community, and iii) 
play an active role in the management of hypertension using predefined interventions[21] to improve 
both the patient’s understanding and control of hypertension in as many as 50% of patients who 
present for all elective surgery.   
 
The volume of surgery performed worldwide, based on population statistics from 2005 to 2013, 
estimates an average imputed surgical rate of 5227 per 100 000 population.[22] With a conservative 
estimate of 20 000 elective (South African Surgical Outcomes Study, unpublished data[23]), adult 
non-cardiac, non-obstetric surgical procedures per annum in the Western Cape, as many as 2000 
(10%) new cases of hypertension could be diagnosed perioperatively. Furthermore, a total of 8000 
(40%) of these patients would require further therapy optimisation in the perioperative period. The 
population attributable risk associated with hypertension for stroke is approximately 50%, and for 
ischaemic heart disease is 40% in South Africa.[21] Optimisation of hypertension therefore could 
prevent 125 strokes and 244 coronary events in this population annually, based on the prevalence of 
stroke and coronary heart disease in our population (2.5% and 6.1% respectively). 
 
Implications for South Africa: 
In South Africa, assuming that half of the national surgical rate is performed in the adult population  
(2614 per 100 000 population),[23] then as many as 261 (10%) per 100 000 new cases of 
hypertension could be diagnosed annually at the time of surgery.  The  perioperative period  could 
also present an opportunity to optimise hypertensive treatment in up to 1046 (40%) per 100 000 
patients with the potential to prevent 16 strokes and 32 coronary events per 100 000 of the adult 






We believe that in South Africa there is a significant potential for public health interventions in the 
perioperative period both in identifying new cases as well as improving management of 
hypertension.  Earlier diagnosis, initiation of treatment and addressing issues of compliance through 
education programs may create stronger links between the referral hospital and primary health care 
facility to improve long term outcomes. This model may be followed to address other chronic 
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		 Assessed for Eligibility (n=397) 
Complete Data Sets 
(n=382) 
Excluded (n=15) 
- Refused consent (n=5) 
- Not meeting inclusion criteria (n=4) 
- Data incomplete (n=6) 
- Declined to participate (n=0) 
ENROLLED 






On treatment (n=157) 
Non-Compliant (n=39) Compliant (n=118) 
BP Controlled (n=99) 
Fig. 1: PRISMA diagram depicting the study recruitment process 
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Age (years) 50; 16.1 41.2; 14.3 58.5; 12.9 <0.001 
 
Gender 
     
Male 146 (38.2) 76 (41.3) 70 (35.4) 0.248 
 
ASA status (n=379)     
ASA I 127 (33.5) 107 (59.1) 20 (10.1) <0.001 
ASA II 187 (49.3) 62 (34.3) 125 (63.1) 
ASA III 59 (15.6) 11 (6.1) 48 (24.2) 
ASA IV 6 (1.6) 1 (0.6) 5 (2.5) 
     
Risk factors for hypertension 
 
    
BMI (n=358) 28.2 (7.2) 26.6 (6.8) 29.7 (7.3) <0.001 
Smoking 160 (41.9) 89 (48.4) 71 (35.9) 0.778 
Dyslipidaemia 48 (12.6) 7 (3.8) 41 (20.7) <0.001 
NIDDM 19 (5.0) 5 (2.7) 14 (7.1) 0.060 
IDDM 42 (11.0) 6 (3.3) 36 (18.2) <0.001 
Men >55 years 55 (14.4) 18 (9.8) 37 (18.7) 0.014 
Women >65 years 46 (12.0) 7 (3.8) 39 (19.7) <0.001 
 
Target organ damage 
 
    
Left ventricular hypertrophy 39 (10.2) 4 (2.2) 35 (17.7) <0.001 
Coronary artery disease 14 (3.7) 2 (1.1) 12 (6.1) 0.012 
Heart failure 5 (1.3) 1 (0.5) 4 (2.0) 0.204 
Chronic kidney disease 27 (10.4) 2 (2.0) 25 (15.7) <0.001 
CVA/TIA 6 (1.6) 1 (0.5) 5 (2.5) 0.120 
Peripheral arterial disease 8 (2.1) 2 (1.1) 6 (3.0) 0.185 
Retinopathy 8 (2.1) 0 (0.0) 8 (4.0) 0.008 
 
Other comorbid disease 
 
    
COPD/Asthma 36 (9.4) 13 (7.1) 23 (11.6) 0.161 
HIV/AIDS 24 (6.3) 16 (8.7) 8 (4.0) 0.090 
 
SD = Standard Deviation; BMI = Body Mass Index; CVA = Cerebrovascular Accident; TIA = Transient 




Table 2. Classification of the severity of hypertension  (n=198) 
 Hypertensive  







Grade 1 - Mild  




Grade 2 - Moderate  




Grade 3 - Severe  





Classification of Hypertension as per 2014 South African Hypertension Practice Guideline.[4] 
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Table 3. Most common anti-hypertensive therapies used    
Antihypertensive Treatment Number (%) 
  
Diuretic 124/198 (62.6) 
ACE-I/ARB 97/198 (49.0) 
B-Blocker 61/198 (30.8) 
Calcium Channel Blocker 46/198 (23.2) 
Alpha-blocker 6/198 (3.0) 
Other 4/198 (2.0) 
 
ACE-I = angiotensin converting enzyme-inhibitor; ARB =  angiotensin receptor blocker  
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%; 95% CI 
 




Standardised questions to elicit non-compliance: 
Do you ever forget to take your medicine? 50/156 32.1; 24.7 – 39.3 
Are you careless at times about taking your 
medicine? 
35/154 22.7; 16.1 – 29.3 
When you feel better do you sometimes stop 
taking your medicine? 
20/155 12.9; 7.6 – 18.2 
Sometimes if you feel worse when taking your 
medication, do you stop taking it? 
 
20/155 12.9; 7.6 – 18.2 
Reasons for non-compliance (n=39):   
Health system 3 /39 7.9; 0.0 – 16.5 
Condition 8 /39 21.1; 8.1 – 34.0 
Patient 22/39 57.9; 42.2 – 73.4 
Therapy 6/39 15.8; 4.2 – 27.3 
Socioeconomic 5/39 13.2; 2.4 – 23.9 
 
	
* Compliance with medical therapy was assessed using the Morisky Medication Adherence 
Questionnaire.[15,16]  
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Patients recruited with 
complete data (n=382) 
George Provincial Hospital secondary 49 49 
Groote Schuur Hospital tertiary 187 179 
Mitchell’s Plain Hospital secondary 28 27 
New Somerset Hospital secondary 45 42 
Paarl Hospital secondary 46 46 
Victoria Hospital secondary 12 10 
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SAMJ RESEARCH ARTICLE guidelines: 
 
Guideline word limit: 4 000 words 
  
Research articles describe the background, methods, results and 
conclusions of an original research study. The article should contain the 
following sections: introduction, methods, results, discussion and 
conclusion, and should include a structured abstract (see below). The 
introduction should be concise – no more than three paragraphs – on the 
background to the research question, and must include references to other 
relevant published studies that clearly lay out the rationale for conducting 
the study. Some common reasons for conducting a study are: to fill a gap 
in the literature, a logical extension of previous work, or to answer an 
important clinical question. If other papers related to the same study have 
been published previously, please make sure to refer to them specifically. 
Describe the study methods in as much detail as possible so that others 
would be able to replicate the study should they need to. Results should 
describe the study sample as well as the findings from the study itself, but 
all interpretation of findings must be kept in the discussion section, which 
should consider primary outcomes first before any secondary or tertiary 
findings or post-hoc analyses. The conclusion should briefly summarise the 
main message of the paper and provide recommendations for further study. 
  
Select figures and tables for your paper carefully and sparingly. Use only 
those figures that provided added value to the paper, over and above what 
is written in the text. 
Do not replicate data in tables and in text . 
  
Structured abstract 
• This should be 250-400 words, with the following recommended 
headings: 
◦ Background: why the study is being done and how it relates to 
other published work. 
◦ Objectives: what the study intends to find out 
◦ Methods: must include study design, number of participants, 
description of the intervention, primary and secondary 
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outcomes, any specific analyses that were done on the data. 
◦ Results: first sentence must be brief population and sample 
description; outline the results according to the methods 
described. Primary outcomes must be described first, even if 
they are not the most significant findings of the study. 
◦ Conclusion: must be supported by the data, include 
recommendations for further study/actions. 
• Please ensure that the structured abstract is complete, accurate and clear 
and has been approved by all authors. 
• Do not include any references in the abstracts. 
  
  
Here is an example of a good abstract. 
  
Main article 
All articles are to include the following main sections: 
Introduction/Background, Methods, Results, Discussion, Conclusions. 
The following are additional heading or section options that may appear 
within these: 
• Objectives (within Introduction/Background): a clear statement of the 
main aim of the study and the major hypothesis tested or research 
question posed 
• Design (within Methods): including factors such as prospective, 
randomisation, blinding, placebo control, case control, crossover, 
criterion standards for diagnostic tests, etc. 
• Setting (within Methods): level of care, e.g. primary, secondary, number 
of participating centres. 
• Participants (instead of patients or subjects; within Methods): numbers 
entering and completing the study, sex, age and any other biological, 
behavioural, social or cultural factors (e.g. smoking status, 
socioeconomic group, educational attainment, co-existing disease 
indicators, etc)that may have an impact on the study results. Clearly 
define how participants were enrolled, and describe selection and 
exclusion criteria. 
• Interventions (within Methods): what, how, when and for how long. 
Typically for randomised controlled trials, crossover trials, and before 
and after studies. 
• Main outcome measures (within Methods): those as planned in the 




• Start with description of the population and sample. Include key 
characteristics of comparison groups. 
• Main results with (for quantitative studies) 95% confidence intervals and, 
where appropriate, the exact level of statistical significance and the 
number need to treat/harm. Whenever possible, state absolute rather 
than relative risks. 
• Do not replicate data in tables and in text. 
• If presenting mean and standard deviations, specify this clearly. Our 
house style is to present this as follows: 
• E.g.: The mean (SD) birth weight was 2 500 (1 210) g. Do not use the ± 
symbol for mean (SD). 
• Leave interpretation to the Discussion section. The Results section should 
just report the findings as per the Methods section. 
  
Discussion 
Please ensure that the discussion is concise and follows this overall 
structure – sub-headings are not needed: 
• Statement of principal findings 
• Strengths and weaknesses of the study 
• Contribution to the body of knowledge 
• Strengths and weaknesses in relation to other studies 
• The meaning of the study – e.g. what this study means to clinicians and 
policymakers 
• Unanswered questions and recommendations for future research 
  
Conclusions 
This may be the only section readers look at, therefore write it carefully. 
Include primary conclusions and their implications, suggesting areas for 
further research if appropriate. Do not go beyond the data in the article. 
  
 
